Guangdong Bawei Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guangdong Bawei Biotechnology Co., Ltd. - overview
Established
2006
Location
-, -, China
Primary Industry
Consumer Products
About
Founded in 2006 and based in China, Guangdong Bawei Biotechnology Co. , Ltd. operates as a cosmetics processing company. Bawei serves nearly 2,000 cosmetic brand customers.
In January 2022, Guangdong Bayway Biotechnology Co. , Ltd. raised CNY 100 million in Series B funding from Baiyun Fund and Jinding Capital. The company provides integrating professional planning, research and development, and production of cosmetics products in the market.
The enterprise plans to use the January 2022 funding to invest in digital intelligence factory renovation to expand production capacity and improve the utilization rate and strengthen the company's technical barriers to competition in the application of raw materials and formula research and development.
Current Investors
Jinding Capital, Baiyun Fund
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene, Biotechnology
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.